Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms

Transplantation

Volumn 78, Issue 5, 2004, Pages 660-667

  Banuelos, Scott J ^a   Markees, Thomas G ^a   Phillips, Nancy E ^a   Appel, Michael C ^a   Cuthbert, Amy ^a   Leif, Jean ^a   Mordes, John P ^a   Shultz, Leonard D ^b   Rossini, Aldo A ^a   Greiner, Dale L ^a,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

^c Biotech 2 ^*  (United States)

Author keywords

CD 154; CD4+CD25+; Costimulation blockade; T regulatory cell; Transplantation tolerance

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEALING; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE; TRANSFUSION; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MODELS, ANIMAL; SKIN TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 4544263376     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000130449.05412.96     Document Type: Article

References (50)

1. Rossini AA, Greiner DL, Mordes JP. Induction of immunological tolerance for transplantation. Physiol Rev 1999; 79: 99.
2. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 1995; 92: 9560.
3. + T cells, interferon-gamma, and CTLA4. J Clin Invest 1998; 101: 2446.
4. Elster EA, Xu H, Tadaki DK, et al. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 2001; 72: 1473.
5. Xu H, Elster E, Batty D, et al. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Transplant Proc 2001; 33: 223.
6. Kenyon NS, Fernandez LA, Lehmann R, et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999; 48: 1473.
7. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999; 96: 8132.
8. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000; 101: 455.
9. + suppressor T cells. J Exp Med 2001; 193: F41.
10. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816.
11. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 2002; 168: 4399.
12. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002; 168: 5979.
13. + regulatory T cells in antimyelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 2002; 99: 8213.
14. Iwakoshi NN, Markees TG, Turgeon NA, et al. Skin allograft maintenance in a new synchimeric model system of tolerance. J Immunol 2001; 167: 6623.
15. Honey K, Cobbold SP, Waldmann H. CD40 ligand blockade induces CD4+T cell tolerance and linked suppression. J Immunol 1999; 163: 4805.
16. + precursors in a thymus-independent process. J Immunol 2004; 172: 923.
17. - regulatory cells mediate dominant transplantation tolerance. J Immunol 2002; 168: 5558.
18. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
19. Karim M, Bushell AR, Wood KJ. Regulatory T cells in transplantation. Curr Opin Immunol 2002; 14: 584.
20. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183.
21. + immunoregulatory cells. J Immunol 2001; 167: 1137.
22. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198: 235.
23. Walker LS, Chodos A, Eggena M, et al. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198: 249.
24. Klein L, Khazaie K, Von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A 2003; 100: 8886.
25. + T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512.
26. Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298.
27. Wells AD, Li XC, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303.
28. Jones ND, Turvey SE, Van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824.
29. Phillips NE, Markees TG, Mordes JP, et al. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol 2003; 170: 3015.
30. Kearney ER, Pape KA, Loh DY, et al. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994; 1: 327.
31. Tafuri A, Alferink J, Möller P, et al. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270: 630.
32. Seung E, Mordes JP, Rossini AA, et al. Hematopoietic chimerism and central tolerance created by peripheral tolerance induction without myeloablative conditioning. J Clin Invest 2003; 112: 795.
33. Noelle RJ, Roy M, Shepherd DM, et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 1992; 89: 6550.
34. Foy TM, Shepherd DM, Durie FH, et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 1993; 178: 1567.
35. Ortega G, Robb RJ, Shevach EM, et al. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells. J Immunol 1984; 133: 1970.
36. Moreau JL, Nabholz M, Diamantstein T, et al. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur J Immunol 1987; 17: 929.
37. Kruisbeek AM. In vivo depletion of CD4- and CD8-specific T cells. In: Coligan JE, Kruisbeek AM, Margulies DH, et al., eds. Current protocols in immunology. New York, Wiley 1994, pp. 4.1.1-4.1.5.
38. Seung E, Iwakoshi N, Woda BA, et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175.
39. Markees TG, Serreze DV, Phillips NE, et al. NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes 1999; 48: 967.
40. Matthews DE, Farewell VT. The log-rank or Mantel-Haenszel test for the comparison of survival curves. In: Matthews DE, Farewell VT, eds. Using and understanding medical statistics. Basel, Karger 1988, pp. 79-87.
41. Lohr J, Knoechel B, Jiang S, et al. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol 2003; 4: 664.
42. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002; 32: 3267.
43. + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci U S A 2003; 100: 10902.
44. Quezada SA, Fuller B, Jarvinen LZ, et al. Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 2003; 102: 1920.
45. + T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulation. Transplantation 2001; 72: 369.
46. Kumanogoh A, Wang X, Lee I, et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development. J Immunol 2001; 166: 353.
47. + T cell-mediated graft rejection: Implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 5401.
48. Bushell A, Karim M, Kingsley CI, et al. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: A potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
49. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
50. + regulatory T cell activity in both humans and mice. J Immunol 2004; 172: 834.